Zobrazeno 1 - 10
of 140
pro vyhledávání: '"Mohammad Shehab"'
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundReal-world data assessing the effectiveness of biologics in patients with inflammatory bowel disease (IBD) in the Middle East are not well-established. In our study, we evaluated the effectiveness of biologic therapies in achieving clinical
Externí odkaz:
https://doaj.org/article/ed2be95e08c849db8c1ad9d8920329aa
Autor:
Husam Ahmad Al Hamad, Mohammad Shehab
Publikováno v:
International Journal of Data and Network Science, Vol 8, Iss 3, Pp 1501-1516 (2024)
Arabic handwritten script recognition presents an energetic area of study. These types of recognitions face several obstacles, such as vast open databases, boundless diversity in individuals' penmanship, and freestyle writing. Thus, Arabic handwritin
Externí odkaz:
https://doaj.org/article/8d4e574aa5ca4ddea76708830fd3998f
Publikováno v:
Gastroenterology Insights, Vol 14, Iss 3, Pp 383-393 (2023)
Introduction: Patients with inflammatory bowel disease (IBD) on biologic therapies are at increased risk of infections, emphasizing the importance of immunization. This study aimed to assess vaccination prevalence among patients with IBD on specific
Externí odkaz:
https://doaj.org/article/81ed1a6ecf114a59b7a48092a05f4c16
Autor:
Husam Ahmad Alhamad, Mohammad Shehab, Mohd Khaled Y. Shambour, Muhannad A. Abu-Hashem, Ala Abuthawabeh, Hussain Al-Aqrabi, Mohammad Sh. Daoud, Fatima B. Shannaq
Publikováno v:
Symmetry, Vol 16, Iss 6, p 681 (2024)
Given the prevalence of handwritten documents in human interactions, optical character recognition (OCR) for documents holds immense practical value. OCR is a field that empowers the translation of various document types and images into data that can
Externí odkaz:
https://doaj.org/article/6f38a4d4a00c404a81f2838d486deb1f
Autor:
Mohammad Shehab, Fatema Alrashed, Munerah Alyaseen, Zainab Safar, Tunrayo Adekunle, Ahmad Alfadhli, Talat Bessissow
Publikováno v:
Vaccines, Vol 12, Iss 4, p 364 (2024)
Introduction: Hepatitis B virus (HBV) infection has been associated with chronic hepatitis and cirrhosis. Patients with inflammatory bowel disease (IBD) may be at a higher risk of HBV infection reactivation, especially those on biologic therapies. Th
Externí odkaz:
https://doaj.org/article/22570f8c40d448248db09be69efad56a
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: About a third of patients with inflammatory bowel disease (IBD) do not respond to anti-tumor necrosis factor (anti-TNF) therapy. In our study, we evaluated the effectiveness of vedolizumab and ustekinumab in achieving clinical and endosco
Externí odkaz:
https://doaj.org/article/27eae7c9cbd344b6bb9e87adf92f8f66
Publikováno v:
JGH Open, Vol 6, Iss 4, Pp 241-250 (2022)
Abstract Background and Aim The use of biologics and small molecules has been a concern for patients with inflammatory bowel disease (IBD) during the COVID‐19 pandemic. We aimed to assess the association between the risk of COVID‐19‐related hos
Externí odkaz:
https://doaj.org/article/16fca20c785c489d9841e0f36c325551
Autor:
Mohamed Abu-Farha, Dhanya Madhu, Prashantha Hebbar, Anwar Mohammad, Arshad Channanath, Sina Kavalakatt, Nada Alam-Eldin, Fatima Alterki, Ibrahim Taher, Osama Alsmadi, Mohammad Shehab, Hossein Arefanian, Rasheed Ahmad, Thangavel Alphonse Thanaraj, Fahd Al-Mulla, Jehad Abubaker
Publikováno v:
Cells, Vol 12, Iss 21, p 2563 (2023)
Background: Angiopoietin-like protein 8 (ANGPTL8) is known to regulate lipid metabolism and inflammation. It interacts with ANGPTL3 and ANGPTL4 to regulate lipoprotein lipase (LPL) activity and with IKK to modulate NF-κB activity. Further, a single
Externí odkaz:
https://doaj.org/article/58af7644c19a46d09ac517ee0f9f76a1
Autor:
Mohammad Shehab, Ali Alali, Ahmed Al-Hindawi, Abdulwahab Alsayegh, Usama Aldallal, Israa Abdullah, Abbas Albaghli, Fatema Alrashed, Ahmad Alfadhli, Talat Bessissow
Publikováno v:
Frontiers in Medicine, Vol 9 (2023)
BackgroundThe impact of biologic therapies on body mass index (BMI) in patients with inflammatory bowel disease (IBD) is unclear. This study investigates any associations between BMI, type of IBD, and the type of medications taken among patients with
Externí odkaz:
https://doaj.org/article/631834b6c4bf4b5189e471d866e9557e
Autor:
Mohammad Shehab, Fatema Alrashed, Ahmad Alfadhli, Abdulwahab Alsayegh, Usama Aldallal, Mariam Alsayegh, Preethi Cherian, Irina Alkhair, Thangavel Alphonse Thanaraj, Arshad Channanath, Ali A. Dashti, Anwar Albanaw, Hamad Ali, Mohamed Abu-Farha, Jehad Abubaker, Fahd Al-Mulla
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
IntroductionFew data exist regarding the immunogenicity of the third dose of BNT162b2 relative to the second dose in patients with inflammatory bowel disease (IBD) on different immunosuppressive therapies. We investigated the immunogenicity of BNT162
Externí odkaz:
https://doaj.org/article/3a274ee2cdc04b8daf41bc28c2d17fcd